Bryan Tate | Philanthropy

Bryan Tate is a dedicated philanthropist

Category: Diabetes

Bryan Tate - Eversense: The Future of Continuous Glucose Monitoring

Eversense: The Future of Continuous Glucose Monitoring

I’ve spoken a bit in the past on the topic of diabetes and how serious it is. I’ve also discussed new artificial pancreases that have the ability to automatically supply insulin to its user. And while those pancreases are still a ways off from becoming widely available, there are other advanced methods that are attempting to reduce the amount of human involvement in regulating glucose levels. With so many technology companies working on this solution, we could soon see a day where those afflicted with diabetes no longer need to worry about monitoring their glucose with invasive finger pricking. One such company, Senseonics, has created a viable solution to constant glucose monitoring.


Eversense is a continuous glucose monitoring system (CGM), which, by itself is nothing new. What makes Eversense stand out from other CGM devices available is its implantable chip technology that lasts up to 90 days. The chip is inserted underneath the skin of the arm, and a removable transmitter is then applied directly over the chip’s location on the outer skin of the arm. This transmitter can then send a signal to the chip in order to activate it; once activated, the chip measures glucose levels in the body’s bloodstream using state-of-the-art fluorescence technology. The transmitter can accurately report the body’s current glucose level and how fast and where it is headed.


You’re probably thinking to yourself that this incredibly smart transmitter requires a specially designed receiver that is either not aesthetically pleasing or is large and incumbent. You’d be wrong. What makes Eversense so unique and attractive is that it makes use of a portable device that you probably would be carrying around with you anyways: your cell phone. Using bluetooth technology, the transmitter can relay the glucose information it receives directly to your smartphone and display it quickly and efficiently using the Eversense app. The application, working in tandem with the transmitter, can then notify you on changes to your glucose levels periodically.


Currently, the device is only available overseas in Germany, Netherlands, Sweden, Italy and Norway. Whether or not it will ever become available in North America is unclear. Regardless, it is truly an innovative device that could pave the way for even less intrusive methods of monitoring glucose levels.
Should any details regarding Eversense’s stateside release emerge, I’ll be sure to keep you posted.

Bryan Tate - Artificial Pancreas Trials to Move Forward

Artificial Pancreas Trials to Move Forward

Dealing with diabetes, like any major disease, is a challenge. One of the most difficult tasks is consistently checking blood sugar levels, which is achieved by pricking a finger in order to draw blood. However, with the rapid advancement of technology, those with diabetes may soon not need to manually check their blood.


According to a recent report from Time, The National Institutes of Health officially announced that they will be funding the last-stage trials of artificial pancreas devices. The devices are meant to solve the issue of manually checking blood sugar by automating the process altogether.


There are devices that already monitor blood sugar and automatically inject insulin when needed. However, these devices, which were approved last October by the U.S. Food and Drug Administration, still require people with diabetes to manually request insulin after they eat.


The new devices being tested are designed specifically to be fully automated and remove any human input whatsoever. One study, which is scheduled to take place in 2018, will be headed by Dr. Steven Russell from the Massachusetts General Hospital and Ed Damiano from Boston University. The study will follow 312 people, aged 18 and older, who will spend six months using a bionic pancreas that uses insulin and glucagon to stabilize blood sugar levels throughout the day.


Damiano’s bionic pancreas came to be after his son was diagnosed with type 1 diabetes. He hopes the bionic pancreas can be improved so that his son will never need to worry about the disease in the future.


In a statement, Dr. Griffin Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases, reinforced the want and need for such a device, and how it would change the world of medicine. “For many people with type 1 diabetes, the realization of a successful, fully automated artificial pancreas is a dearly held dream. Nearly 100 years since the discovery of insulin, a successful artificial pancreas would mark another huge step toward better health for people with type 1 diabetes.”
Major technological breakthroughs such as these are exactly what we need in the world of medicine. Not only for those suffering from diabetes, but any other affliction, from cancer to Parkinson’s. Hopefully, these tests will prove fruitful, and at least provide a temporary solution while scientists come up with a cure once and for all.